Expertise in
19
conditions

Thierry Passeron

Nice, FR 
Expertise in
19
conditions
Nice, FR 

Overview

Thierry Passeron practices practicing medicine in Nice, France.

Passeron is highly rated in 19 conditions, according to our data. Their clinical expertise encompasses Melasma, Vitiligo, Hypomelanotic Disorder, and Liver Spots.

They are actively involved in clinical research, co-authoring 394 peer reviewed articles and participating in 2 clinical trials.

Locations

Nice, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Effect and Tolerance of the Association of Baricitinib (4 mg) and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo: a Randomized, Double-blind, Prospective, Non-comparative Phase II Study.
Evaluation of Effect and Tolerance of the Association of Baricitinib (4 mg) and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo: a Randomized, Double-blind, Prospective, Non-comparative Phase II Study.
Enrollment Status: Completed
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drug: Baricitinib Oral Product
Study Phase: Phase 2
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

394 Total Publications

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.
Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.
Journal: JAMA dermatology
Published: August 12, 2026

Frequently Asked Questions about Thierry Passeron

Is Thierry Passeron a top-rated expert for Melasma?

MediFind is an objective health platform that identifies experts based on real-world data. Thierry Passeron is classified as an Elite expert for Melasma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thierry Passeron participate in research or clinical trials?

Yes. Thierry Passeron has published 394 articles and abstracts on conditions like Melasma. You can view a list of Thierry Passeron's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Passeron's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 8 Advanced Conditions
View All 58 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile